首页|期刊导航|时珍国医国药|基于数据挖掘技术的中药熏洗法治疗膝关节骨性关节炎的用药规律探讨

基于数据挖掘技术的中药熏洗法治疗膝关节骨性关节炎的用药规律探讨OA

Analysis on medication rules of Chinese herbal fumigation and washing therapy for knee osteo-arthritis based on data mining

中文摘要英文摘要

目的 运用数据挖掘技术分析中药熏洗法治疗膝关节骨性关节炎的临床处方用药规律.方法 计算机检索中文数据库(中国知网(CNKI)、万方数据库(Wanfang)、维普数据库(VIP))和英文数据库(PubMed、Web of Science)在线电子数据库自建库至2024年12月31日收录的中药熏洗法治疗膝关节骨性关节炎的临床研究,通过Excel表格建立中药电子处方数据库,选用SPSS 22.0、Origin Pro和SPSS modeler 18.0中Apriori算法,对处方中高频用药进行统计描述、聚类分析及关联规则分析.结果 共纳入858篇符合纳排标准的文献,涉及中药237味,中药使用累计频次10934次,涉及18类中药,以祛风湿药、活血化瘀药为主.药物使用频次前5位的中药依次为:红花、透骨草、伸筋草、牛膝、威灵仙,其中高频用药(>150次)的性味以辛、温、苦为主,归经依次为肝经、脾经、肾经.聚类分析将药物分为5类,涉及活血化瘀药、祛风湿药、解表药、补益药、理气药等.关联规则分析得到9条药物配伍组合,其中支持度较高的中药组合依次为乳香-没药,川乌-草乌-伸筋草,乳香-没药-透骨草、没药-乳香-伸筋草,乳香-没药-红花等.结论 中药熏洗法治疗膝关节骨性关节炎的处方用药紧密围绕"寒、湿、瘀、虚"的病因病机,以祛风湿药及活血化瘀药为主,辅以补益药、解表药,突出了"祛风除湿、活血化瘀、温经通络、滋补肝肾"的核心治法,具有疗效明确、标本兼治的特点.

Objective To analyze the clinical prescription and medication rules of Chinese herbal fumigation and washing therapy for knee osteoarthritis(KOA)using data mining techniques.Methods A systematic search was conducted in Chinese databases(CNKI,Wanfang,VIP)and English databases(PubMed,Web of Science)to collect clinical studies on Chinese herbal fumigation and washing therapy for KOA,with publication dates ranging from the establishment of each database to December 31,2024.An electronic database of herbal prescriptions was established using Excel.SPSS 22.0,OriginPro,and SPSS Modeler 18.0(with the Apriori algorithm)were used for statistical description,cluster analysis,and association rule mining of high-frequency Chinese medicinals(CMs).Results A total of 858 eligible articles were included,involving 237 CMs with a cumulative usage frequency of 10,934 times,covering 18 catego-ries of CMs.Wind-dampness-dispelling herbs and blood-activating and stasis-resolving herbs were the main categories.The top 5 herbs in terms of usage frequency were:Flos Carthami,Herba Speranskiae Tuberculatae,Herba Lycopodii,Radix Achyranthis Bidentatae,and Radix Clematidis.The nature and flavor of high-frequency herbs(with a usage frequency>150 times)were mainly pungent,bitter,and warm,and their meridian tropisms were primarily the liver meridian,spleen meridian,and kidney meridian in sequence.Cluster analysis categorized the herbs into 5 groups,including blood-activating and stasis-resolving herbs,wind-dampness-dispelling herbs,exterior-releasing herbs,tonic herbs,and qi-regulating herbs.Association rule analysis identified 9 combinations of herb compatibility,among which the most supported combinations were Resina Olibani-Resina Myrrhae,Radix Aconiti-Radix Aconiti Kusnezoffii-Herba Lycopodii,Resina Olibani-Resina Myrrhae-Herba Lycopodii,Resina Myrrhae-Resina Olibani-Herba Lycopodii,Resina Olibani-Resina Myrrhae-Flos Carthami,etc.Conclusion The prescriptions of Chinese herbal fumigation and washing therapy for KOA are closely based on the etiology and pathogenesis of"cold,dampness,stasis,and deficiency",with wind-dampness-dispelling herbs and blood-activating and stasis-resolving herbs as the core components,supplemented by tonic herbs and exterior-releasing herbs.This prescription strategy reflects the core therapeutic principles of"dispelling wind and removing dampness,activating blood cir-culation and resolving stasis,warming meridians and collaterals,and nourishing the liver and kidneys",and is characterized by definite efficacy and treating both the symptoms and the root cause.

倪国栋;潘泉汐;马增斌;孙悦礼;陈江;郑志坚;徐浩;王拥军

上海中医药大学,上海 201203||上海中医药大学附属龙华医院,上海 200032||北京医院,国家老年医学中心,中国医学科学院老年医学研究院,北京 100730北京市大兴区中西医结合医院,北京 100076北京医院,国家老年医学中心,中国医学科学院老年医学研究院,北京 100730上海中医药大学,上海 201203||上海中医药大学附属龙华医院,上海 200032北京中医药大学东直门医院,北京 100700北京医院,国家老年医学中心,中国医学科学院老年医学研究院,北京 100730上海中医药大学,上海 201203||上海中医药大学附属龙华医院,上海 200032上海中医药大学,上海 201203||上海中医药大学附属龙华医院,上海 200032

医药卫生

膝关节骨性关节炎熏洗疗法用药规律聚类分析数据挖掘

Knee osteoarthritisChinese herbal fumigation and washing therapyMedication rulesCluster analysisData mining

《时珍国医国药》 2026 (16)

3141-3147,7

中央高水平医院临床科研业务费项目(BJ-2024-205)国家自然科学基金重点项目(81930116)国家自然科学基金面上项目(81273849)北京中医药大学教育教学改革专项(XJZ25049)中华中医药学会足踝专项(CACM-2025-GSKY03-B17)上海市重大临床研究项目(SHDC2020CR1010A)

10.70976/j.1008-0805.SZGYGY-2026-1621

评论